Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia

New England Journal of Medicine

Volumn 335, Issue 10, 1996, Pages 708-714

  Schipani, E ^a   Langman, C B ^b   Parfitt, A M ^c   Jensen, G S ^a   Kikuchi, S ^d   Kooh, S W ^e   Cole, W G ^e   Juppner H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CALCIUM; CYCLIC AMP; DNA; HISTIDINE; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN; PROLINE; THREONINE;

ADOLESCENT; ADULT; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CHILD; CHONDRODYSPLASIA; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; METAPHYSIS; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; SHORT LIMBED DWARFISM;

BASE SEQUENCE; CHILD; DNA MUTATIONAL ANALYSIS; DWARFISM; FEMALE; HETEROZYGOTE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OSTEOCHONDRODYSPLASIAS; PEDIGREE; POINT MUTATION; RECEPTOR, PARATHYROID HORMONE, TYPE 1; RECEPTORS, PARATHYROID HORMONE;

EID: 0029849784     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609053351004     Document Type: Article

References (32)

1. Jansen M. Über atypische Chondrodystrophie (Achondroplasie) und über eine noch nicht beschriebene angeborene Wachstumsstörung des Knochensystems: Mctaphysäre Dysostosis. Orthop Chir 1934;61:253-86.
2. Cameron JAP, Young WB, Sissons HA. Metaphysial dysostosis: report of a case. J Bone Joint Surg Br 1954;36:622-9.
3. Gram PE, Fleming JL, Frame B, Fine G. Metaphyseal chondrodysplasia of Jansen. J Bone Joint Surg Am 1959;41:951-9.
4. de Haas WHD, de Boer W, Griffioen F. Metaphysial dysostosis: a late follow-up of the first reported case. J Bone Joint Surg Br 1969;51:290-9.
5. Holthusen W, Holt JF, Stoeckenius M. The skull in metaphyseal chondrodysplasia type Jansen. Pediatr Radiol 1975;3:137-44.
6. Rao DS, Frame B, Reynolds WA, Parfitt AM. Hypercalcemia in metaphyseal chondrodysplasia of Jansen (MCD): an enigma. In: Norman AW, Schaefer K, von Herrath D, et al., eds. Vitamin D, basic research and its clinical application. Berlin, Germany: Walter de Gruyter, 1979:1173-6.
7. Frame B, Poznanski AK. Conditions that may be confused with rickets. In: DeLuca HF, Anast CS, eds. Pediatric diseases related to calcium. New York: Elsevier, 1980:269-89.
8. Silverthorn KG, Houston CS, Duncan BE Murk Jansen's metaphyseal chondrodysplasia with long-term followup. Pediatr Radiol 1987;17:119-23.
9. Kessel D, Hall CM, Shaw DG. Two unusual cases of nephrocalcinosis in infancy. Pediatr Radiol 1992;22:470-1.
10. Kruse K, Schütz C. Calcium metabolism in the Jansen type of metaphyseal dysplasia. Eur J Pediatr 1993;152:912-5.
11. Jüppner H. Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors. Curr Opin Nephrol Hypertens 1994;3:371-8.
12. Urena P, Kong XF, Abou-Samra AB, et al. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 1993;133:617-23.
13. Tian J, Smogorzewski M, Kedes L, Massry SG. Parathyroid hormone/ parathyroid hormone related protein receptor messenger RNA is present in many tissues besides the kidney. Am J Nephrol 1993;13:210-3.
14. Lee K, Deeds JD, Chiba S, Un-No M, Bond AT, Segre GV. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: in situ localization of its receptor and c-fos messenger ribonucleic acids. Endocrinology 1994;134:441-50.
15. Lee K, Brown D, Ureña P, et al. Localization of parathyroid hormoneparathyroid hormone-related peptide receptor mRNA in kidney. Am J Physiol 1996;270:F186-F191.
16. Schipani E, Kruse K, Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995;268:98-100.
17. Reed A, Haugen M, Pachman LM, Langman CB. Abnormalities in serum osteocalcin values in children with chronic rheumatic diseases. J Pediatr 1990;116:574-80.
18. Gordon SL, Varano LA, Alandete A, Maisels MJ. Jansen's metaphyseal dysostosis. Pediatrics 1976;58:556-60.
19. Kikuchi S, Hasue M, Watanabe M, Hascbc K. Metaphysial dysostosis (Jansen type): report of a case with long follow-up. J Bone Joint Surg Br 1976;58:102-6.
20. Charrow J, Poznanski AK. The Jansen type of metaphyseal chondrodysplasia: confirmation of dominant inheritance and review of radiographic manifestations in the newborn and adult. Am J Med Genet 1984;18:321-7.
21. Schipani E, Weinstein LS, Bergwitz C, et al. Pseudohypoparathyroidism type lb is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 1995;80:1611-21.
22. Schipani E, Hustmyer FG, Bergwitz C, Jüppner H. Polymorphism in exon M7 of the PTHR gene. Hum Mol Genet 1994;3:1210.
23. Lenz WD. Discussion. In: Bergsma D, ed. The First Conference on the Clinical Delineation of Birth Defects. Part 4. Skeletal dysplasias. Vol. 5. No. 4 of Birth defects: original article series. New York: National Foundation, 1969:71-2.
24. Ren Q, Kurose H, Lefkowitz RJ, Cotecchia S. Constitutively active mutants of the α 2-adrenergic receptor. J Biol Chem 1993;268:16483-7. [Erratum, J Biol Chem 1994;269:1566.]
25. Iwamoto M, Jikko A, Murakami H, et al. Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem 1994;269:17245-51.
26. Lee K, Deeds JD, Segre GV. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acid during fetal development of rats. Endocrinology 1995;136:453-63.
27. Jikko A, Murahami H, Yan W, et al. Effects of cyclic adenosine 3′,5′-monophosphate on chondrocyte terminal differentiation and cartilage-matrix calcification. Endocrinology 1996;137:122-8.
28. Karapiis AG, Luz A, Glowacki I, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 1994;8:277-89.
29. Lanske B, Karapiis AC, Lee K, et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996; 273:663-6.
30. Weir E, Philbrick W, Neff L, Amling M, Baron R, Broadus A. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes skeletal dysplasia:and delayed osteogenesis. J Bone Miner Res 1995; 10:Suppl 1:S157. abstract.
31. Jaffe HL. Metabolic, degenerative, and inflammatory diseases of bones and joints. Philadelphia: Lea & Febiger, 1972:222-6.
32. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995;121:3539-47.